FDA fast tracks Amgen’s Blincyto leukemia drug
Thousand Oaks-based biotech giant Amgen announced March 29 that the U.S. Food and Drug Administration has fast-tracked the company’s leukemia drug Blincyto for priority review. The drug increases the length of survival among high-risk patients, according to a study released by the New England Journal of Medicine. It almost doubled median overall survival versus chemotherapy among adult patients Read More →
MindBody acquires dynamic pricing technology company
Business management software company MindBody, based in San Luis Obispo, announced March 29 that it had acquired early-stage Southern California yield management company Lymber Wellness. Lymber uses MindBody’s application program interface platform to support adjustable pricing strategies for wellness-based businesses. The technology changes the prices for classes and appointments based on availability, similar to dynamic Read More →
Limoneira shareholders approve request to increase number of shares
Limoneira shareholders approved a board of directors request to increase its number of authorized shares March 28, but the company has no plans to issue additional stock this year, said CEO Harold Edwards. More than 100 shareholders gathered at the Ventura County Agriculture Museum in Santa Paula for the annual meeting to confirm three new Read More →
Pacific Premier shareholders approve acquisition of Heritage Oaks
Pacific Premier Bancorp shareholders have voted to approve the acquisition of Paso Robles-based Heritage Oaks Bancorp, Pacific Premier said March 28. The all-stock deal, announced Dec. 13, is valued at $405.6 million or $11.68 per share. It combines the region’s largest bank, with $2 billion in assets, and Pacific Premier, which has $3.8 billion in assets, Read More →
Law firm probing Sientra board of directors
The law firm of Brodsky & Smith has announced an investigation into the board of directors at Sientra, a breast implant manufacturing firm based in Goleta. According to a news release from the law firm, the investigation comes after previous litigation. The complaint alleges that the defendants made false and misleading statements, including failing to Read More →
500 Amgen employees to be re-assigned, relocated or laid off
Nearly 500 Amgen employees in Thousand Oaks have been notified that they will be re-assigned, relocated or laid off as part of a restructuring plan. The biotech giant informed employees on March 22 that they will be reassigned to a new Tampa Bay, Fla. facility and research and development offices in Cambridge, Mass. and South Read More →